Frailty and cognitive impairment are not reasons to withhold anticoagulation in people with atrial fibrillation but screening could guide management

Stephanie L Harrison, Asangaedem Akpan, Gregory Y H Lip

Research output: Contribution to journalEditorial

3 Citations (Scopus)

Abstract

Oral anticoagulants (OACs) reduce the risk of stroke for people with atrial fibrillation (AF), and OACs are recommended in evidence-based guidelines for most people with AF.1 The net clinical benefit of OACs compared with no treatment or aspirin is clear for most people with AF, apart from those at lowest stroke risk.2 The common risk factors for incident AF are also risk factors for stroke and bleeding in AF.3
Original languageEnglish
Pages (from-to)1807-1810
Number of pages4
JournalJournal of the American Geriatrics Society
Volume69
Issue number7
Early online date24 Apr 2021
DOIs
Publication statusPublished - Jul 2021
Externally publishedYes

Keywords

  • Frailty
  • Atrial fibrillation
  • Cognitive impairment
  • Oral anticoagulants
  • Stroke

Fingerprint

Dive into the research topics of 'Frailty and cognitive impairment are not reasons to withhold anticoagulation in people with atrial fibrillation but screening could guide management'. Together they form a unique fingerprint.

Cite this